1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
2 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | 2025 | |
|---|---|---|
| Revenue | 0 | 100.00% |
| Gross profit | 0 | 100.00% |
| Net profit | -5.94m | 501.83% |
| EBITDA | -640.94k | 28.29% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.96m |
Number of shares | 946.24k |
52-week high/low | €8.98 - €1.76 |
| Dividends | No |
Beta | 0.45 |
P/E ratio | -0.75 |
PEG ratio | 0.01 |
P/B ratio | -21.08 |
P/S ratio | 0.00 |
Company profile
| Name | XTL Biopharmaceuticals ADR |
| CEO | Noam Band |
| Employees | 10 |
